期刊文献+

唑来膦酸与云克治疗恶性肿瘤骨转移疼痛的对比研究 被引量:2

下载PDF
导出
摘要 目的探讨唑来膦酸与云克治疗恶性肿瘤骨转移疼痛的临床疗效。方法64例患者分为唑来膦酸组32例和云克组32例,唑来膦酸组用唑来膦酸注射液4mg加入生理盐水100ml,静脉滴注15min。云克组用云克100mg加入250—500ml静脉滴注3h,连用7d。2组用药10d后观察疗效并比较。结果唑来膦酸组完全缓解11例,部分缓解16例,轻微缓解1例,无缓解4例,镇痛有效率为84.4%;云克组完全缓解7例,部分缓解13例,轻微缓解7例,无缓解5例,镇痛有效率为62.5%。2组间比较差异有统计学意义(Χ^2=3.92,P〈0.05)。结论唑来膦酸治疗恶性肿瘤骨转移疼痛效果较云克好,安全可靠,使用方便,值得临床推广。
出处 《中国医药》 2007年第12期746-747,共2页 China Medicine
  • 相关文献

同被引文献22

  • 1于佩瑶,张敏,朱青山,刘基巍.唑来膦酸治疗恶性肿瘤骨转移疼痛临床观察[J].中国医师进修杂志,2006,29(4):22-24. 被引量:4
  • 2Fukuoka M , Yann S , Giaccone G , et al. Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-lung cancer. J Clin Oncol, 2003, 6 (21) :2237-2246.
  • 3Herbst RS , Maddox AM, Rothenberg ML, et al. Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-lung cancer and other solid tumors: results of a phase I trial. J Clin Oncol , 2002,8(20) :3815-3825.
  • 4Kris MG , Natale RB , Herbst RS , et al. Efficacy of gefitinib , an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small-lung cancer: a randomized trial. JAMA,2003,10(290) :2149-2158.
  • 5Tamura K, Fukuoka M. Gefitinib in non-small-lung cancer. Expert Opin Pharmacother,2005,12(6) :985-993.
  • 6郑涛,曹华,徐敏,叶建增,王树滨,申维玺.唑来膦酸治疗骨转移引起疼痛的临床观察[J].中国医师进修杂志,2007,30(9):39-40. 被引量:1
  • 7Coleman RE. Metastatic bone disease:clinical features,pathophysiology and treatment strategies[J].Cancer Treatment Reviews,2001,(03):165-176.
  • 8Rosen LS,Gordon D,Tchekmedyian NS. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors:a randomized,Phase Ⅲ,double-blind,placebo-controlled trial[J].Cancer,2004,(12):2613-2621.doi:10.1002/cncr.20308.
  • 9Black DM,Delmas PD,Eastell R. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis[J].New England Journal of Medicine,2007,(18):1809-1822.doi:10.1056/NEJMoa067312.
  • 10Matczak E,Hirsh V,Lipton A. Effects of zoledronic acid on survival in patients with lung cancer and high baseline N-telopeptide (NTX) levels:Stratified by baseline bone alkaline phosphatase (BALP)[J].Journal of Clinical Oncology,2006,(Suppl):7228.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部